Ocera Therapeutics Inc Stock

Stocks

17-11-02	Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Ocera Therapeutics, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
17-10-20	Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®	GL
17-08-23	Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017	GL
17-08-01	Ocera Therapeutics Reports Second Quarter 2017 Financial Results	GL
17-06-01	Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
OCERA THERAPEUTICS INC	-.--%	+2.29%	-	-	0
REGENERON PHARMACEUTICALS, INC.	-0.33%	+1.83%	+24.73%	-6.86%	68.85B
UCB	+0.67%	+0.93%	+36.86%	+197.49%	52.13B
SAMSUNG BIOLOGICS CO.,LTD.	+0.94%	+39.60%	+39.60%	+39.60%	43.46B
CSL LIMITED	+1.12%	+0.35%	-52.09%	-53.39%	41.24B
BIOGEN INC.	-1.40%	+3.43%	+64.81%	-25.41%	30.41B
MODERNA, INC.	-2.11%	-9.45%	+97.76%	-49.58%	24.53B
INCYTE CORPORATION	+0.51%	+0.46%	+72.78%	+90.09%	23.42B
INNOVENT BIOLOGICS, INC.	-5.57%	-0.84%	-0.11%	+182.38%	19.75B
SWEDISH ORPHAN BIOVITRUM AB	-0.86%	-1.99%	+70.03%	+117.01%	16.57B
Average	-0.70%	-0.81%	+39.37%	+54.59%	35.6B
Weighted average by Cap.	-0.34%	-0.07%	+32.55%	+46.83%